Entos Finds $53M For Drug Design Platform
socalTECH
JULY 16, 2021
San Diego-based Entos, a developer of artificial intelligence and automated synthetic development technology for designing small-molecule therapeutics, has raised $53M in a Series A funding. Entos was founded by Tom Miller (CEO), Fred Manby (CTO), and Naren Gupta (Managing Director of Nexus Venture Partners).
Let's personalize your content